CytRx Corp
CYTR
CYTR was delisted on the 3rd of June, 2019.
0 hedge funds and large institutions have $0 invested in CytRx Corp in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $115 → $0 (-$115)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
Archer Investment Corporation
Carmel,
Indiana
|
-$115 |
CYTR Hedge Fund Activity: Q1 2023 in Review
0 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in CytRx Corp (CYTR) for Q1 2023, worth a combined $0 — down 100% from $115 a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CYTR and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Archer Investment Corporation, exiting entirely with an estimated $115 sold.
- 0 institutional investors held CytRx Corp (CYTR) as of Q1 2023, down from 1 in Q4 2022.
- Funds reported $0 of CytRx Corp stock for Q1 2023, down 100% quarter-over-quarter.
- 0 funds opened new CytRx Corp positions in Q1 2023 and 1 closed out, a net change of -1 holder.
- The largest CytRx Corp seller in Q1 2023 was Archer Investment Corporation, an estimated $115 sold.
Based on aggregated 13F filings for Q1 2023.